Letter to the Director

Cystic Fibrosis New-born Screening in a Portuguese centre – are we complying with European recommendations?

Main Article Content

Bernardo Camacho
Carolina Constant
Luísa Pereira
Celeste Barreto
Keywords:
cystic fibrosis, newborn screening, Neonatal Screening, diagnosis

Abstract

No abstract (letter to the editor).

Article Details

How to Cite
Section
Letter to the Director

References

Travert G, Heeley M, Heeley A. History of Newborn Screening for Cystic Fibrosis-The Early Years. Int J Neonatal Screen. 2020;6:8. doi: 10.3390/ijns6010008.

Marcão A, Barreto C, Pereira L, Vaz LG, Cavaco J, Casimiro A, et al. Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies. Int J Neonatal Screen. 2018;4:22. doi: 10.3390/ijns4030022.

Nayir Buyuksahin H, Emiralioglu N, Ozsezen B, Ademhan Tural D, Sunman B, Guzelkas I, et al. Cystic fibrosis newborn screening: Five-year experience from a tertiary care center. Pediatr Pulmonol. 2022;57:403-10. doi: 10.1002/ppul.25778.

Naehrlich L. The Changing Face of Cystic Fibrosis and Its Implications for Screening. Int J Neonatal Screen. 2020;6:54. doi: 10.3390/ijns6030054.

Castellani C, Duff AJ, Bell SC, Heijerman HG, Munck A, Ratjen F, et al. ECFS best practice guidelines: the 2018 revision. J Cyst Fibros. 2018;17:153-78. doi: 10.1016/j.jcf.2018.02.006.

Barben J, Castellani C, Dankert-Roelse J, Gartner S, Kashirskaya N, Linnane B, et al. The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. J Cyst Fibros. 2017;16:207-13. doi: 10.1016/j.jcf.2016.12.012.